Caricamento...
Tumor necrosis factor inhibitors in psoriatic arthritis
INTRODUCTION: Psoriatic arthritis (PsA) is a chronic inflammatory disease that can result in significant disability. With the emergence of tumor necrosis factor inhibitors (TNFi), therapeutic outcomes in PsA have improved substantially. The clinical efficacy and the inhibition of radiographic progre...
Salvato in:
| Pubblicato in: | Expert Rev Clin Pharmacol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6348387/ https://ncbi.nlm.nih.gov/pubmed/28490202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17512433.2017.1329009 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|